| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/29/2008 | US20080124301 Oligonucleotide for use in prevention and treatment of cell proliferative and nervous system disorders; antisense agents |
| 05/29/2008 | US20080124284 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with Porphyromonas gingivalis |
| 05/29/2008 | US20080124280 Thyroid Hormone Analogs and Methods of Use |
| 05/29/2008 | US20080124278 characterized by a modification at the conserved N-linked site in the CH2 domains of the Fc portion of said antibody; useful in the treatment and prevention of diseases that involve undesirable immune responses |
| 05/29/2008 | US20080124277 Human and Mouse Targeting Peptides Identified by Phage Display |
| 05/29/2008 | US20080124272 antibodies against influenza neuraminidase antigens; monoclonal antibody or antigen binding fragment |
| 05/29/2008 | DE202008000834U1 Zusammensetzung und Reagenz für CTLA-4 und Verwendungen derselben Composition and reagent for CTLA-4 and uses thereof |
| 05/29/2008 | DE102007041812A1 Einzelkettiger Pan-ecto-nox (SCFV)-Antikörper mit variabler Region, kodierende Sequenz sowie Verfahren Single chain Pan-ecto-nox (SCFV) antibody variable region coding sequence and methods |
| 05/29/2008 | CA2687468A1 Live bacterial vaccine |
| 05/29/2008 | CA2670368A1 Neutralizing monoclonal antibodies against the nogo-66 receptor (ngr) and uses thereof |
| 05/29/2008 | CA2670288A1 Methods of treating chronic inflammatory diseases using a gm-csf antagonist |
| 05/29/2008 | CA2670097A1 Prime boost canine leishmania vaccine |
| 05/29/2008 | CA2670039A1 Novel antiproliferation antibodies |
| 05/29/2008 | CA2670025A1 Multicomponent vaccine |
| 05/29/2008 | CA2669982A1 Combination therapy for proliferative disorders |
| 05/29/2008 | CA2669765A1 Use of clostridium perfringens type c bacterium for the manufacture of a vaccine |
| 05/29/2008 | CA2669558A1 Compositions and methods related to toll-like receptor-3 |
| 05/29/2008 | CA2669544A1 Biodegradable t-cell activation device and methods |
| 05/29/2008 | CA2669424A1 Antagonists of pcsk9 |
| 05/29/2008 | CA2669209A1 Use of lipid containing particles comprising quillaja saponins for the treatment of cancer |
| 05/29/2008 | CA2668649A1 Methods of enhancing immune response using electroporation-assisted vaccination and boosting |
| 05/29/2008 | CA2667802A1 Multiple sclerosis therapy |
| 05/29/2008 | CA2666709A1 Method for treating age-related macular degeneration |
| 05/29/2008 | CA2665839A1 Polypeptide ligands for targeting cartilage and methods of use thereof |
| 05/29/2008 | CA2665644A1 Antibodies to lymphotoxin-alpha |
| 05/28/2008 | EP1925941A1 Method for prediction of the efficacy of vascularization inhibitor |
| 05/28/2008 | EP1925662A1 Recombinant Poxvirus-Cytomegalovirus Compositions and uses |
| 05/28/2008 | EP1925319A1 Pharmaceutical compositions containing sc(fv)2 |
| 05/28/2008 | EP1925318A1 Recombinant modified vaccinia virus Ankara (MVA)-based vaccine for the avian flu |
| 05/28/2008 | EP1925317A1 Stabilised mRNA tumour vaccins |
| 05/28/2008 | EP1925315A2 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 05/28/2008 | EP1925309A1 Novel anticancer concomitant drug |
| 05/28/2008 | EP1924607A1 Fas binding antibodies |
| 05/28/2008 | EP1924606A2 Devices, compositions and methods for the protection and repair of cells and tissues |
| 05/28/2008 | EP1924605A1 Compositions and methods for diagnosing and treating an inflammation |
| 05/28/2008 | EP1924604A1 Human monoclonal antibodies that specifically bind igf-ii |
| 05/28/2008 | EP1924603A2 Prok2 antagonists and methods of use |
| 05/28/2008 | EP1924602A1 Intravenous immunoglobulin composition |
| 05/28/2008 | EP1924597A2 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants |
| 05/28/2008 | EP1924293A1 Composition and method for prevention and treatment of type i diabetes |
| 05/28/2008 | EP1924287A2 Method of treating depression using a tnf-alpha antibody |
| 05/28/2008 | EP1924286A1 Phrophylactic and/or therapeutic method for treatment of autoimmune disease |
| 05/28/2008 | EP1924285A1 Detecting molecular complexes |
| 05/28/2008 | EP1924284A1 Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides |
| 05/28/2008 | EP1924283A1 Compositions comprising immunostimulatory rna oligonucleotides and methods for producing said rna oligonucleotides |
| 05/28/2008 | EP1924282A2 Immunization of avians by administration of non-replicating vectored vaccines |
| 05/28/2008 | EP1924281A2 Modified influenza virus for monitoring and improving vaccine efficiency |
| 05/28/2008 | EP1924280A2 Vaccination against dengue virus infection |
| 05/28/2008 | EP1924279A2 Adjuvanted vaccine |
| 05/28/2008 | EP1592449B1 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 05/28/2008 | EP1537243B1 Method of diagnosing ovarian endometriosis |
| 05/28/2008 | EP1490106B1 Use of a lipopeptide or lipoprotein as an adjuvant in therapeutic or prophylactic vaccinations |
| 05/28/2008 | EP1420819B1 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 05/28/2008 | EP1377251B1 A cell therapy method for the treatment of tumors |
| 05/28/2008 | EP1343476B1 Preparation of large liposomes by infusion into peg |
| 05/28/2008 | EP1326982B1 Basb205 polypeptides and polynucleotides coding therefor |
| 05/28/2008 | EP1246925B1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 05/28/2008 | EP1196587B1 Antigenic meningococcal peptides |
| 05/28/2008 | EP1159298B1 Hiv peptides, antigens and vaccine compositions |
| 05/28/2008 | EP1009759B1 Carbohydrate crosslinked glycoprotein crystals |
| 05/28/2008 | EP0998567B1 Cloned genomes of infectious hepatitis c viruses and uses thereof |
| 05/28/2008 | EP0968295B1 Vectors having enhanced expression and methods of making and uses thereof |
| 05/28/2008 | CN101189334A 抗cd14抗体融合蛋白质 Anti-cd14 antibody fusion proteins |
| 05/28/2008 | CN101189266A Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 05/28/2008 | CN101189265A Anti-IL2 antibodies |
| 05/28/2008 | CN101189254A 疫苗 Vaccine |
| 05/28/2008 | CN101189028A Identification and engineering of antibodies with variant Fc regions and methods of using the same |
| 05/28/2008 | CN101189027A Prrs vaccines |
| 05/28/2008 | CN101189026A Vaccine compositions and methods for the treatment of urinary incontinence |
| 05/28/2008 | CN101189014A Methods and means for the treatment of hpv induced intraepithelial neoplasias |
| 05/28/2008 | CN101188996A Surface-modified microparticles and methods of forming and using the same |
| 05/28/2008 | CN101187652A Unmethylated CpG dinucleotide content detection method |
| 05/28/2008 | CN101186920A High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) |
| 05/28/2008 | CN101186902A Pseudorabies virus SA215, pseudorabies virus polygene deletion bacterin and preparation method thereof |
| 05/28/2008 | CN101186650A Antibody against secreted N-terminal peptide or C-terminal peptide of GPC3 present in blood |
| 05/28/2008 | CN101186648A Pseudomonas aeruginosa resisting Fab' fragment |
| 05/28/2008 | CN101185757A Vaccine containing composite adjuvant and preparation method thereof |
| 05/28/2008 | CN101185756A Brucella molecule marking and virulence deletion attenuated vaccine and preparation method |
| 05/28/2008 | CN101185755A Cryptocaryon irritans larva oil adjuvant killed vaccine and preparation method thereof |
| 05/28/2008 | CN101185754A Novel MHC II associated peptides |
| 05/28/2008 | CN100390289C Method for producing influenza hemagglutinin multivalent vaccines |
| 05/28/2008 | CN100390288C Multivalent antibodies and uses therefor |
| 05/28/2008 | CN100390279C Altered polypeptides with increased half-life |
| 05/28/2008 | CN100390196C Hybrid and tandem expression of neisserial proteins |
| 05/28/2008 | CN100390195C Modulators of function of FAS receptors and other proteins |
| 05/28/2008 | CN100389831C Gene engineering vaccine used for preventing pig cysticercosis and its preparation method |
| 05/28/2008 | CN100389827C Vaccine preparation for active immunity, its use and preparing method |
| 05/28/2008 | CN100389826C Remedies for arthritis |
| 05/28/2008 | CN100389825C Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies |
| 05/28/2008 | CN100389824C 联合疫苗组合物 Combined vaccine composition |
| 05/28/2008 | CN100389823C Preparation method of hepatitis vaccine and its use |
| 05/28/2008 | CN100389773C Novel helicobacter pylori-binding substances and use thereof |
| 05/27/2008 | US7378495 PTH-rP related peptide cancer therapeutics |
| 05/27/2008 | US7378490 a cyclic dodecapeptide containing Arg, Asp, Ala, Glu, Ser, Gly, Ala; cyclic peptides serve as antigens for producing a neutralizing antibody capable of neutralizing HIV-1 virus infection via the second receptors called CXCR4 and CCR5 |
| 05/27/2008 | US7378445 Treatment of prostate cancer |
| 05/27/2008 | US7378411 Substituted thienopyrimidinones as a mitotic kinesin inhibitor |
| 05/27/2008 | US7378389 Neurotoxic component has been purified from a botulinum toxin by fermenting a Clostridium botulinum to botulinum toxin type A; promotion of normal muscle growth |
| 05/27/2008 | US7378386 inhibiting viral replication or infection by contacting a composition with a virally infected cell with a cell impervious cephalin-binding ligand or proteins; treating an animal with a viral infection; hepatitis, influenza, AIDS, viral pneumonia or respiratory disease |
| 05/27/2008 | US7378272 Mosquito cell culture for propagation of sindbis viral vectors; genetic engineering and vehicles for gene transfer |
| 05/27/2008 | US7378258 Antibodies; transcription regulators; bacterial infections; vectors; host cells |